Related Experiment Videos
Extended surgery--left upper abdominal exenteration plus Appleby's method--for type 4 gastric carcinoma
H Furukawa1, M Hiratsuka, T Iwanaga
1Department of Surgery, Center for Adult Diseases, Osaka, Japan.
Annals of Surgical Oncology
|April 1, 1997
Summary
Extended surgery improved survival for stage III type 4 gastric cancer patients. However, this approach did not benefit stage IV patients, indicating a need for new treatment strategies.
Area of Science:
- Surgical Oncology
- Gastrointestinal Surgery
- Gastric Cancer Research
Background:
- Type 4 gastric cancer, including linitis plastica, has a poor prognosis with frequent retroperitoneal recurrence.
- Extended surgery, left upper abdominal exenteration plus the Appleby's method (LUAE + Apl), has been used for type 4 cancers since 1983 to achieve complete tumor removal.
- The study evaluates the efficacy of LUAE + Apl for advanced gastric cancer.
Purpose of the Study:
- To evaluate the outcomes of extended surgery (LUAE + Apl) for type 4 gastric cancer.
- To compare the survival rates of patients undergoing LUAE + Apl with those who had conventional surgery.
- To identify the optimal application of the LUAE + Apl procedure.
Main Methods:
- A total of 54 patients with type 4 gastric cancer underwent LUAE + Apl.
- The LUAE + Apl procedure involves en bloc removal of the stomach, pancreas, spleen, gallbladder, transverse colon, and left adrenal gland.
- Patient outcomes were compared between the extended surgery group (Group A) and a historical control group (Group B) who underwent common surgery.
Main Results:
- Postoperative complications included pancreatic fistula (30% vs. 19% in controls) and liver dysfunction (15% vs. 14%).
- The 5-year survival rate for stage III patients in Group A (40%) was significantly better than in Group B (20%; p < 0.05).
- For stage IV patients, the 5-year survival rate was not improved by LUAE + Apl (5% in Group A vs. 3% in Group B).
Conclusions:
- LUAE + Apl improves survival for stage III scirrhous gastric cancer.
- This extended surgical approach is not effective for improving survival in stage IV gastric cancer.
- Novel treatment concepts and supportive therapies are required to enhance survival for stage IV gastric cancer patients.